Founder and CEO of monARC Bionetworks, Komathi Stem is passionate about transforming drug development by rethinking the way clinical trials are designed and executed. She is focused on sparking an ecosystem change that accelerates research through greater collaboration. Stem has 24 years of pharmaceutical and biotech industry experience as a senior global leader at Genentech, AstraZeneca and Eli Lilly, where she built and led multifunctional global departments. For the past five years, she led a global innovation team at Genentech that tested patient centric solutions for accelerating clinical research and reducing costs.
Stem, who holds a master’s degree in biomedical engineering, has broad pharma/biotech leadership experience ranging from global clinical operations, strategic innovation, portfolio management, medical affairs and sales/marketing.